» Articles » PMID: 22338582

Widespread Decreases in Cortical Muscarinic Receptors in a Subset of People with Schizophrenia

Overview
Specialty Psychiatry
Date 2012 Feb 18
PMID 22338582
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

These studies were undertaken to investigate the selectivity of cortical muscarinic receptor radioligand binding in muscarinic M(1) and M(4) receptor knockout mice and to determine whether a marked decrease in [(3)H]pirenzepine binding in Brodmann's area (BA) 9 from a subset of people with schizophrenia was predictive of decreased muscarinic receptors in other central nervous system (CNS) regions. Our data show that, under the conditions used, [(3)H]pirenzepine binding was highly selective for the muscarinic M(1) receptor whereas both [(3)H]AF-DX 386 and [(3)H]4DAMP had less discriminatory power. In addition, the data suggest that a marked decrease in [(3)H]pirenzepine binding in BA 9 from a subset of people with schizophrenia is predictive of decreases in muscarinic receptors in other CNS regions. However, there were some region-specific decreases in muscarinic receptors in tissue from people with schizophrenia who were outside this subset. These data add to a growing body of evidence suggesting there are widespread decreases in muscarinic receptors in the CNS of some subjects with schizophrenia, as demonstrated by neuroimaging. Our data have implications for understanding the potential clinical utility of drugs directed at the orthosteric and allosteric sites of muscarinic receptors to treat schizophrenia.

Citing Articles

A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia.

Dean B, Bakker G, Ueda H, Tobin A, Brown A, Kanaan R Front Cell Neurosci. 2023; 17:1124333.

PMID: 36909280 PMC: 9992992. DOI: 10.3389/fncel.2023.1124333.


Markers of muscarinic deficit for individualized treatment in schizophrenia.

Stuke H Front Psychiatry. 2023; 13:1100030.

PMID: 36699495 PMC: 9868756. DOI: 10.3389/fpsyt.2022.1100030.


Involvement of muscarinic receptors in psychomotor hyperactivity in dopamine-deficient mice.

Fujita M, Ochiai Y, Hagino Y, Kobayashi K, Pavey G, Dean B Mol Brain. 2022; 15(1):96.

PMID: 36447257 PMC: 9710075. DOI: 10.1186/s13041-022-00984-x.


Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function.

Weber L, Tomiello S, Schobi D, Wellstein K, Mueller D, Iglesias S Elife. 2022; 11.

PMID: 35502897 PMC: 9098218. DOI: 10.7554/eLife.74835.


Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition.

Dean B, Scarr E NPJ Schizophr. 2021; 7(1):44.

PMID: 34521861 PMC: 8440523. DOI: 10.1038/s41537-021-00174-z.